These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17264487)

  • 1. Complement, innate immunity and ocular disease.
    Sohn JH; Bora PS; Jha P; Tezel TH; Kaplan HJ; Bora NS
    Chem Immunol Allergy; 2007; 92():105-114. PubMed ID: 17264487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement system in ocular diseases including uveitis and macular degeneration.
    Jha P; Bora PS; Bora NS
    Mol Immunol; 2007 Sep; 44(16):3901-8. PubMed ID: 17768108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doyne lecture 2016: intraocular health and the many faces of inflammation.
    Dick AD
    Eye (Lond); 2017 Jan; 31(1):87-96. PubMed ID: 27636226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
    Taylor AW; Kaplan HJ
    Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement in ocular pathology.
    Bora NS; Jha P; Bora PS
    Semin Immunopathol; 2008 Apr; 30(2):85-95. PubMed ID: 18299835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory mechanisms of the eye.
    Streilein JW
    Prog Retin Eye Res; 1999 May; 18(3):357-70. PubMed ID: 10192517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A renewed appreciation for ocular immune privilege.
    Niederkorn JY
    Arch Soc Esp Oftalmol; 2005 Aug; 80(8):437-8; 439-40. PubMed ID: 16136394
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Privilege and Eye-Derived T-Regulatory Cells.
    Keino H; Horie S; Sugita S
    J Immunol Res; 2018; 2018():1679197. PubMed ID: 29888291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of inflammation on ocular immune privilege.
    Mo JS; Wang W; Kaplan HJ
    Chem Immunol Allergy; 2007; 92():155-165. PubMed ID: 17264491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular immune privilege.
    Taylor AW
    Eye (Lond); 2009 Oct; 23(10):1885-9. PubMed ID: 19136922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior chamber-associated immune deviation.
    Biros D
    Vet Clin North Am Small Anim Pract; 2008 Mar; 38(2):309-21, vi-vii. PubMed ID: 18299009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eye: A window to the soul of the immune system.
    Perez VL; Saeed AM; Tan Y; Urbieta M; Cruz-Guilloty F
    J Autoimmun; 2013 Sep; 45():7-14. PubMed ID: 23871641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regulatory role for complement in innate immunity and autoimmunity.
    Nauta AJ; Roos A; Daha MR
    Int Arch Allergy Immunol; 2004 Aug; 134(4):310-23. PubMed ID: 15218334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
    Streilein JW
    J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.
    Jha P; Sohn JH; Xu Q; Nishihori H; Wang Y; Nishihori S; Manickam B; Kaplan HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1030-8. PubMed ID: 16505038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement regulation in the eye: implications for age-related macular degeneration.
    Wilke GA; Apte RS
    J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection.
    Ligocki AJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):813-23. PubMed ID: 26934137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.